<?xml version="1.0" encoding="UTF-8"?><rss
version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
> <channel><title>Commentaires sur : Sanofi-aventis et Kyowa Hakko Kirin signent un accord de collaboration et de licence sur un anticorps monoclonal humain anti-LIGHT</title> <atom:link href="http://www.mypharma-editions.com/sanofi-aventis-et-kyowa-hakko-kirin-signent-un-accord-de-collaboration-et-de-licence-sur-un-anticorps-monoclonal-humain-anti-light/feed" rel="self" type="application/rss+xml" /><link>http://www.mypharma-editions.com/sanofi-aventis-et-kyowa-hakko-kirin-signent-un-accord-de-collaboration-et-de-licence-sur-un-anticorps-monoclonal-humain-anti-light</link> <description>L&#039;Info Industrie &#38; Politique de Santé</description> <lastBuildDate>Tue, 31 Jan 2012 09:10:38 +0000</lastBuildDate> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <generator>http://wordpress.org/?v=3.3.1</generator> </channel> </rss>
